Eli Lilly’s stock leaps toward a record as a 16% jump in prices boosted profit

U.S. prices for Lilly’s drugs climbed 27%, driven by diabetes treatment Mounjaro, while prices outside the U.S. fell.

Previous post Morgan Stanley’s five reasons why European stocks will prove pessimists wrong in 2024
Next post Plug Power’s stock loses a bull with company seen in ‘triage’ mode